$Different dose combinations of bortezomib and dexamethasone in the treatment of relapsed or refractory myeloma： an open-label,observational, multi-center study in China$

Different dose combinations of bortezomib and dexamethasone in the treatment of relapsed or refractory myeloma： an open-label,observational, multi-center study in China

Background Although previous clinical study revealed that bortezomib combined with dexamethasone had improved the outcomes of relapsed or refractory multiple myeloma （RRMM）, the optimal dose combinations of bortezomib and dexamethasone remain unknown. This trial aimed to observe the efficacy and saf...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Chinese medical journal 2011-10, Vol.124 (19), p.2969-2974
Hauptverfasser:	Yuan, Zhen-Gang, Jin, Jie, Huang, Xiao-Jun, Li, Yan, Chen, Wen-Ming, Liu, Zhuo-Gang, Chen, Xie-Qun, Shen, Zhi-Xiang, Hou, Jian
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Agents - administration & dosage Antineoplastic Agents, Hormonal - administration & dosage Antineoplastic Combined Chemotherapy Protocols - therapeutic use Boronic Acids - administration & dosage Bortezomib China Dexamethasone - administration & dosage Drug Therapy, Combination Female Humans Male Middle Aged Multiple Myeloma - drug therapy Neoplasm Recurrence, Local Prospective Studies Pyrazines - administration & dosage 中国地塞米松复发多中心多发性骨髓瘤最佳剂量标签治疗
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!